By Regulatory Approvals — FDA approves targeted therapy for metastatic pancreatic cancer following UCLA-led study UCLA Health
Read the original at Regulatory Approvals ↗
Auto-published by the finit.news Events monitor from Regulatory Approvals; summarized by AI and may contain errors — verify against the primary source. August 27, 2026.